Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Christopher KennardEmeritus Professor of Clinical Neurology, Professor Christopher Kennard joins the Medical Sciences Division as its new interim Head of Division today, replacing Professor Alastair Buchan, who will be taking a new role as the University’s Head of Brexit Strategy. Professor Kennard knows the Division well, having served, until his retirement late last year, as the Head of the Nuffield Department of Clinical Neuroscience, one of the 16 departments within the Division. Prior to his arrival in Oxford, Prof Kennard was the Deputy Principal for the Faculty of Medicine at Imperial College, London.

Professor Christopher Kennard commented:  “It is a great honour to have been invited by the VC to take on the role of interim Head of the Medical Sciences Division, following Alastair Buchan’s move to become the Head of Brexit Strategy for the University. During his nine year tenure he successfully led the Division to its premier international position and made major contributions in many areas. I very much look forward to being able to contribute to the Division’s continuing success and to work with such an exceptionally talented group of teachers and researchers.”

Professor Louise Richardson, Vice-Chancellor, said: “I am deeply grateful to Professor Christopher Kennard for agreeing to assume the role of Head of Division on an interim basis until a new Head of Division is appointed. The Division sought Council’s approval for the process of selecting a new Head of Division, and we expect to have a new head in place before Professor Alastair Buchan’s term would ordinarily have concluded.”

Similar stories

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).